封面
市场调查报告书
商品编码
1936735

全球磁振造影导引神经外科消融市场规模、份额、趋势和成长分析报告(2026-2034年)

Global MRI Guided Neurosurgical Ablation Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计 MRI 导引神经外科消融市场规模将从 2025 年的 7,763.7 亿美元成长到 2034 年的 15,701.7 亿美元,2026 年至 2034 年的复合年增长率为 8.14%。

由于神经系统疾病盛行率不断上升以及对微创手术技术的需求日益增长,全球磁振造影引导神经外科消融市场预计将迎来显着成长。磁振造影引导神经外科消融术利用磁振造影(MRI)引导消融手术,为肿瘤、癫痫和慢性疼痛等疾病提供精准有效的治疗方法。该技术不仅提高了手术精度,还能最大限度地减少对周围健康组织的损伤,从而改善患者预后并缩短復原时间。随着医疗机构寻求应用更先进的治疗方法,对磁振造影导引神经外科消融术的需求预计将显着成长。

此外,磁振造影(MRI)和消融技术的进步预计将进​​一步推动市场发展。高场MRI系统和创新消融设备的研发提升了神经外科医师的能力,使他们能够更精准地完成更复杂的手术。同时,即时成像和导航系统的整合也提高了神经外科手术的安全性和有效性。随着研究不断发现MRI引导消融的新应用领域,市场有望涌现大量创新解决方案,以满足患者和医疗服务提供者不断变化的需求。

此外,以患者为中心的医疗保健理念日益受到重视,以及降低医疗成本的趋势,预计将塑造磁振造影引导神经外科消融术市场的未来。随着患者对治疗方案的了解增多,他们对微创手术和缩短住院时间的需求也日益增长。磁振造影导引神经外科消融术恰好满足了这些需求,并提供了一种有效的治疗选择,能够提高患者满意度。医疗设备製造商、医疗服务提供者和监管机构之间的合作对于推动这些创新至关重要,并确保磁振造影引导神经外科消融术市场能够持续适应不断变化的神经外科和患者照护需求。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球磁振造影导引神经外科消融市场(依产品划分)

  • 市场分析、洞察与预测
  • 磁共振导引射频消融系统
  • 磁振造影导引雷射消熔系统
  • 磁共振引导聚焦超音波系统
  • 配件

5. 全球MRI导引神经外科消融市场(依最终用途划分)

  • 市场分析、洞察与预测
  • 医院
  • 诊所
  • 门诊手术中心

6. 全球MRI引导神经外科消融市场(按地区划分)

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商格局(基于现有资讯)
  • 策略规划

第八章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Siemens Healthineers AG
    • Monteri
    • Profound Medical
    • Insightec
    • Medtronic
    • Boston Scientific Corporation
    • AngioDynamics
    • ClearPoint Neuro Inc
    • Elekta
    • Accuray Incorporated
简介目录
Product Code: VMR11212301

The MRI Guided Neurosurgical Ablation Market size is expected to reach USD 1570.17 Billion in 2034 from USD 776.37 Billion (2025) growing at a CAGR of 8.14% during 2026-2034.

The global MRI-guided neurosurgical ablation market is set to experience substantial growth, driven by the increasing prevalence of neurological disorders and the rising demand for minimally invasive surgical techniques. MRI-guided neurosurgical ablation offers a precise and effective approach to treating conditions such as tumors, epilepsy, and chronic pain by utilizing magnetic resonance imaging to guide the ablation process. This technology not only enhances the accuracy of the procedure but also minimizes damage to surrounding healthy tissue, leading to improved patient outcomes and faster recovery times. As healthcare providers seek to adopt advanced treatment modalities, the demand for MRI-guided neurosurgical ablation is expected to rise significantly.

Moreover, advancements in MRI technology and ablation techniques are anticipated to further boost the market. The development of high-field MRI systems and innovative ablation devices is enhancing the capabilities of neurosurgeons, allowing for more complex procedures to be performed with greater precision. Additionally, the integration of real-time imaging and navigation systems is improving the safety and efficacy of neurosurgical interventions. As research continues to uncover new applications for MRI-guided ablation, the market is likely to witness an influx of innovative solutions that cater to the evolving needs of patients and healthcare providers.

In addition, the growing emphasis on patient-centric care and the increasing focus on reducing healthcare costs are expected to shape the future of the MRI-guided neurosurgical ablation market. As patients become more informed about their treatment options, there is a rising demand for procedures that offer minimal invasiveness and shorter hospital stays. MRI-guided neurosurgical ablation aligns with these preferences, providing effective treatment options that enhance patient satisfaction. Collaborative efforts between medical device manufacturers, healthcare providers, and regulatory bodies will be essential in driving these innovations, ensuring that the MRI-guided neurosurgical ablation market remains responsive to the evolving landscape of neurosurgery and patient care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • MRI Guided RF Ablation Systems
  • MRI Guided Laser Ablation Systems
  • MRI Guided Focused Ultrasound Systems
  • Accessories

By End Use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

COMPANIES PROFILED

  • Siemens Healthineers AG, Monteri, Profound Medical, Insightec, Medtronic, Boston Scientific Corporation, AngioDynamics, ClearPoint Neuro Inc, Elekta, Accuray Incorporated

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. MRI Guided RF Ablation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. MRI Guided Laser Ablation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. MRI Guided Focused Ultrasound Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET: BY END USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End Use
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End Use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End Use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End Use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End Use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End Use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL MRI GUIDED NEUROSURGICAL ABLATION INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Siemens Healthineers AG
    • 8.2.2 Monteri
    • 8.2.3 Profound Medical
    • 8.2.4 Insightec
    • 8.2.5 Medtronic
    • 8.2.6 Boston Scientific Corporation
    • 8.2.7 AngioDynamics
    • 8.2.8 ClearPoint Neuro Inc
    • 8.2.9 Elekta
    • 8.2.10 Accuray Incorporated